Skanttr

What Skanttr does

Skanttr Lifescience LLP is a privately held, Gujarat-based pharmaceutical manufacturer focused on Active Pharmaceutical Ingredients (APIs) and intermediates, organized as an LLP and operating from a single >14,000 sq.m facility in Bavla, Ahmedabad. The portfolio comprises 42 commercial APIs and 48 intermediates spanning cardiovascular, anti-diabetic, anti-fungal, anti-infective, CNS, oncology-support, vitamin and nutraceutical segments, with named commercial APIs including Benfotiamine, Clotrimazole, Imeglimin HCl, Sacubitril-Valsartan Complex, and Deferasirox. Manufacturing is anchored by WHO-GMP certification, Written Confirmation (WC) approval for select APIs, DMF readiness, and ICH Q7A-compliant operations supported by GLP-certified QC and FDA-inspected microbiology laboratories, with production methods combining chemical synthesis, fermentation, extraction and biotechnology.

The company's most distinctive product is Prussian Blue API and Finished Dosage Form, approved by India's DRDO and CDSCO, which makes Skanttr the first and only authorized manufacturer in India of the only effective treatment for radioactive Cesium, Thallium and Rubidium poisoning - opening a defense and government-stockpile channel alongside commercial pharma. Beyond catalogue sales, Skanttr operates a CDMO/CMO service offering 100+ ready, validated API technologies covering technology transfer, pilot batches, market-specific exclusive agreements, and long-term strategic supply partnerships across EU, US, Gulf and Asia.

The business operates a B2B, quote-based, multi-year contract revenue model with three streams: API manufacturing and sales, custom API synthesis (mg-scale to multi-tonne batches), and contract manufacturing (CMO/CDMO). Customers include generic pharmaceutical companies, CDMO partners, nutraceutical firms, veterinary pharma companies, and government/defense agencies. Distribution is direct (no intermediaries), supported by international exhibitions (IPHEB Russia 2026, FCE Pharma Brazil 2026, Pharmaconex Egypt 2026), company blog content, and direct sales outreach. The company is bootstrapped, family-led (four Managing Directors from the Radadiya family with Rakesh Radadiya and Dhruvil Radadiya named as key leaders), and reports no external funding or M&A activity.

Name

Skanttr

Legal name

Skanttr Lifescience LLP

Website

https://skanttr.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

51–100 employees

Short description

Skanttr Lifescience LLP is an India-based, privately held manufacturer of Active Pharmaceutical Ingredients and intermediates, offering 42 APIs and CDMO services to global generic pharma, nutraceutical, veterinary, and government/defense customers from its WHO-GMP facility in Gujarat.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredient (API) Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule API Commercial Manufacturing (HLAGAHAB)

akta.pro secondary industries

Small-Molecule API & Intermediates CDMO (HLAGABAA), Small-Molecule API Process Development & Route Scouting (HLAGAHAA), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Active pharmaceutical ingredients
• Pharmaceutical API manufacturing
• Contract development manufacturing
• Pharmaceutical intermediates
• Generic API supply

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. API Manufacturing and Sales: Manufacturing and sale of Active Pharmaceutical Ingredients (APIs) and intermediates to pharmaceutical companies globally. Products include 42 APIs and 48 intermediates across therapeutic segments.
2. Contract Manufacturing (CMO/CDMO): Contract development and manufacturing services for pharmaceutical companies. Offers technology transfer manufacturing, market-specific exclusive agreements, and long-term strategic supply partnerships. Multiple engagement models including pure contract manufacturing and volume-based commercial contracts.
3. Custom API Synthesis: Tailored molecule development and custom synthesis services for specialty or high-potency molecules. Scalable from mg-scale lab samples to multi-ton commercial batches.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Skanttr Lifescience LLP manufactures and sells Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates from a WHO-GMP certified facility in Ahmedabad, India, supplying 42 commercial APIs and 48 intermediates across therapeutic segments such as cardiovascular, anti-diabetic, anti-infective, anti-fungal, oncology, ophthalmic, neurovitamins, and respiratory applications. The company also delivers Contract Development and Manufacturing (CDMO/CMO) services and custom API synthesis, including custom scale-up from milligram lab samples to multi-ton commercial batches. A distinct offering is the manufacture of Prussian Blue API and Finished Dosage Form, approved by the Government of India (DRDO & CDSCO), making Skanttr the first and only authorized manufacturer in India of the antidote for radioactive Cesium, Thallium, and Rubidium poisoning.

Product overview

Skanttr Lifescience is a pharmaceutical company specializing in Active Pharmaceutical Ingredients (APIs) and intermediates. The portfolio includes 42 commercial APIs and 48 intermediates across multiple therapeutic segments including cardiovascular, neurology, anti-infective, anti-diabetic, anti-fungal, and nutraceutical APIs. The company offers custom API synthesis and CDMO/CMO services for contract development and manufacturing. Key commercial APIs include Benfotiamine, Clotrimazole, Sacubitril-Valsartan Complex, Imeglimin Hydrochloride, Deferasirox, and various antibiotics, cardiovascular drugs, and neurological medications. The company also manufactures Prussian Blue API (approved by DRDO and CDSCO for treatment of radioactive poisoning). Services include custom API manufacturing, technology transfer, and regulatory documentation support with 100+ ready API technologies.

Differentiator

Problem solved

Functional benefit

Products and services

• Prussian Blue API and Finished Dosage Form Active Pharmaceutical Ingredient and finished dosage form of Prussian Blue approved by the Government of India (DRDO & CDSCO) and globally recognized by USFDA and WHO as the only effective treatment for radioactive Cesium, Thallium, and Rubidium poisoning, stockpiled by governments, nuclear plants, and defense agencies to protect frontline workers and civilians from radiological threats.
• CDMO/CMO Services Contract Development and Manufacturing (CDMO/CMO) services offering process development, optimization, commercial API manufacturing, and regulatory documentation support, with 100+ validated ready API technologies available for transfer across multiple engagement models including market-specific exclusive agreements and long-term strategic supply partnerships.
• Custom API Manufacturing Custom synthesis of pharmaceutical APIs for specialty or high-potency molecules with tailored specifications, covering the full range from milligram-scale laboratory samples to multi-ton commercial batches and including process development for complex molecule needs.
• API Intermediates Commercial pharmaceutical intermediates supplied for use in API synthesis, spanning product families such as 1-(3-Methyl-1-Phenyl-1H-Pyrazol-5-yl)piperazine, (S)-tert-Butyl 4-Oxo-2-(thiazolidine-3-Carbonyl)pyrrolidine-1-carboxylate, 4,5-Dichloro-2-nitroaniline, Trans 4-Amino cyclohexanol, and 2-Amino-3,5-dibromobenzaldehyde.
• Benfotiamine API Vitamin API targeting diabetic neuropathy applications, supplied in IH, JP, and KP grades with WHO-GMP, Written Confirmation, and DMF regulatory support; CAS No. 22457-89-2.
• Clotrimazole API Anti-fungal API supplied in IP, BP, EP, USP, and JP grades with WHO-GMP, Written Confirmation, and DMF support for use in topical anti-fungal formulations; CAS No. 23593-75-1.
• Sacubitril-Valsartan Complex API Cardiovascular API for use in heart failure formulations, supplied in IH grade with DMF support; CAS No. 936623-90-4.
• Imeglimin Hydrochloride API Anti-diabetic API supplied in IH grade with DMF regulatory support for use in type 2 diabetes mellitus formulations.
• Rosuvastatin Calcium API Anti-hyperlipoproteinemic (cholesterol-lowering) API supplied in IP, BP, EP, USP grades with GMP and DMF support, used in cardiovascular and lipid-lowering formulations; CAS No. 147098-20-2.
• Teneligliptin Hydrobromide Hydrate API Anti-diabetic API supplied in IH and IP grades with GMP and DMF support for type 2 diabetes mellitus formulations; CAS No. 1572583-29-9.
• Aceclidine HCl API Active Pharmaceutical Ingredient for ophthalmology applications, supplied to ophthalmic drug formulators; CAS No. 827-61-2.
• Brexpiprazole API Active Pharmaceutical Ingredient for CNS antipsychotic applications supplied for psychiatric drug formulations; CAS No. 913611-97-9.
• Brivaracetam API Active Pharmaceutical Ingredient for CNS anti-epileptic applications supplied for neurology drug formulations; CAS No. 357336-20-0.
• Indacaterol Maleate API Active Pharmaceutical Ingredient for respiratory and COPD applications supplied for long-acting bronchodilator formulations; CAS No. 753498-25-8.
• Levosimendan API Active Pharmaceutical Ingredient used in cardiovascular inotropic therapy for acute decompensated heart failure; CAS No. 141505-33-1.
• Roflumilast API Active Pharmaceutical Ingredient used in respiratory therapy for COPD exacerbations; CAS No. 162401-32-3.
• Tiotropium Bromide API Active Pharmaceutical Ingredient for respiratory applications supplied for long-acting anticholinergic formulations in COPD therapy; CAS No. 136310-93-5.
• Bicalutamide HCl API Active Pharmaceutical Ingredient for oncology applications supplied for prostate cancer therapy formulations; CAS No. 90357-06-5.
• Deferasirox API Active Pharmaceutical Ingredient for iron chelation therapy supplied for chronic iron overload treatment formulations; CAS No. 201530-41-8.
• Deferiprone API Active Pharmaceutical Ingredient for iron chelation therapy supplied for chronic iron overload treatment formulations; CAS No. 30652-11-0.
• Dorzolamide HCl API Active Pharmaceutical Ingredient for ophthalmic applications supplied for glaucoma treatment formulations; CAS No. 130693-82-2.
• Ferric Carboxymaltose API Active Pharmaceutical Ingredient for injectable iron applications supplied for iron deficiency anemia formulations; CAS No. 9007-72-1.
• Glycopyrronium Bromide API Active Pharmaceutical Ingredient for anticholinergic indications supplied for systemic and inhaled formulations; CAS No. 51186-83-5.
• Linezolid API Active Pharmaceutical Ingredient for anti-infective applications supplied for antibiotic therapy formulations; CAS No. 165800-03-3.
• Olanzapine API Active Pharmaceutical Ingredient for CNS applications supplied for antipsychotic formulations; CAS No. 132539-06-1.
• Olanzapine Pamoate API Active Pharmaceutical Ingredient for long-acting injectable antipsychotic therapy; CAS No. 163521-12-8.
• Olopatadine HCl API Active Pharmaceutical Ingredient for anti-allergic applications supplied for allergic rhinitis and conjunctivitis formulations; CAS No. 140462-76-6.
• Ranolazine API Active Pharmaceutical Ingredient for cardiovascular anti-anginal therapy supplied to chronic angina drug formulators; CAS No. 95635-55-5.
• Azathioprine API Active Pharmaceutical Ingredient for immunosuppressant applications supplied for transplant and autoimmune disease formulations; CAS No. 446-86-6.
• Bupivacaine HCl API Local anesthetic API supplied in IH, IP, BP, and USP grades with GMP and DMF support for use in surgical and regional anesthesia formulations; CAS No. 73360-54-0.
• Colestipol HCl API Active Pharmaceutical Ingredient for lipid lowering applications supplied for cholesterol management formulations; CAS No. 26658-42-4.
• Cyclophosphamide API Active Pharmaceutical Ingredient for oncology and immunosuppressant indications supplied for chemotherapy formulations; CAS No. 50-18-0.
• Deflazacort API Active Pharmaceutical Ingredient for steroid applications supplied for anti-inflammatory formulations; CAS No. 14484-47-0.
• Ketoprofen API Active Pharmaceutical Ingredient for NSAID applications supplied for pain and anti-inflammatory drug formulations; CAS No. 22071-15-4.
• Pregabalin API Active Pharmaceutical Ingredient for anti-convulsant applications supplied for neuropathic pain and epilepsy formulations; CAS No. 148553-50-8.
• Selegiline HCl API Active Pharmaceutical Ingredient for CNS applications supplied for Parkinson's disease formulations; CAS No. 14611-52-0.
• Acyclovir API Active Pharmaceutical Ingredient for antiviral applications supplied for herpes virus infection formulations; CAS No. 59277-89-3.
• Albendazole API Active Pharmaceutical Ingredient for anti-parasitic applications supplied for helminth infection formulations; CAS No. 54965-21-8.
• Allopurinol API Active Pharmaceutical Ingredient for anti-gout applications supplied for hyperuricemia and gout formulations; CAS No. 315-30-0.
• Ambroxol HCl API Active Pharmaceutical Ingredient for mucolytic and respiratory therapy supplied for cough and respiratory formulations; CAS No. 23828-92-4.
• Fluconazole API Active Pharmaceutical Ingredient for anti-fungal applications supplied for systemic and topical anti-fungal formulations; CAS No. 86386-73-4.
• Fluoxetine HCl API Active Pharmaceutical Ingredient for SSRI antidepressant therapy supplied for depression and anxiety formulations; CAS No. 56296-78-7.
• Lidocaine HCl API Local anesthetic API supplied for cardiac arrhythmia and anesthesia formulations; CAS No. 6108-05-0.
• Pantoprazole API Active Pharmaceutical Ingredient for proton pump inhibitor (PPI) applications supplied for acid reflux and ulcer formulations; CAS No. 102625-70-7.
• Terbinafine API Active Pharmaceutical Ingredient for systemic anti-fungal applications supplied for dermatophyte infection formulations; CAS No. 91161-71-6.
• Sulbutiamine API Neurovitamin API in Skanttr's neurovitamin product line for nerve and metabolic health support supplied for nutraceutical and pharmaceutical formulations.
• Fursultiamine API Neurovitamin API in Skanttr's neurovitamin product line for nerve and metabolic health support supplied for nutraceutical and pharmaceutical formulations.
• Bisbenthiamine API Neurovitamin API in Skanttr's neurovitamin product line for nerve and metabolic health support supplied for nutraceutical and pharmaceutical formulations.
• Thiamine Disulfide API Neurovitamin API in Skanttr's neurovitamin product line for nerve and metabolic health support supplied for nutraceutical and pharmaceutical formulations.
• Acefylline API Bronchodilator agent API supplied in IP, BP, and USP grades with GMP and DMF support for respiratory formulations; CAS No. 652-37-9.
• Acebrofylline API Bronchodilator agent API supplied in IH and KP grades with GMP and DMF support for respiratory formulations; CAS No. 96989-76-3.
• Cyclizine Hydrochloride API Antihistamine API supplied in IP, BP, EP, and USP grades with GMP and DMF support for nausea and travel sickness formulations; CAS No. 303-25-3.
• Ciprofloxacin Hydrochloride API Antibiotic API supplied in IP grade with GMP and DMF support for bacterial infection formulations; CAS No. 93107-08-5.
• Artemether API Anti-malarial API supplied in IP and USP grades with GMP and DMF support for malaria treatment formulations; CAS No. 71963-77-4.
• Lumefantrine API Anti-malarial API supplied in IP and USP grades with GMP and DMF support, typically co-formulated with artemether for malaria treatment; CAS No. 82186-77-4.

Quantifiable outcome

• 36 months shelf life for packaged APIs under controlled storage conditions
• +2 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Laurus Labs: Indian API manufacturer with strong CDMO franchise and a broad portfolio of small-molecule APIs across anti-infective, cardiovascular, and other therapeutic segments. Directly comparable in product categories and B2B go-to-market.
• Neuland Laboratories: India-based API manufacturer and CDMO offering contract development, custom synthesis, and commercial API supply across therapeutic categories. Closely comparable to Skanttr's hybrid API/CDMO business at similar mid-tier scale.
• Dishman Carbogen Amcis: India-based CDMO offering API development, custom synthesis, and commercial manufacturing for global pharma. Comparable to Skanttr's contract manufacturing and custom synthesis offerings.
• Sai Life Sciences: Indian CRDMO offering contract API development and manufacturing services across small molecules. Comparable to Skanttr's CDMO/CMO service line and focus on complex molecule development and technology transfer.
• Divi's Laboratories: One of India's largest API manufacturers and CDMOs, specializing in custom synthesis and generic APIs across therapeutic segments. Highly comparable to Skanttr's API + CDMO business model, though at significantly larger scale.
• Granules India: Indian API and finished formulation manufacturer with focus on high-volume, cost-competitive small-molecule APIs. Comparable to Skanttr in API product categories and B2B generic-pharma customer base.
• Morepen Laboratories: Indian API manufacturer with diversified small-molecule API portfolio across multiple therapeutic segments and active exports to regulated markets. Comparable in product breadth and export orientation.
• Honour Lab: Indian pharmaceutical manufacturer with WHO-GMP-certified API manufacturing facilities supplying regulated global markets. Closely comparable to Skanttr's GMP-certified API manufacturing model and export focus.

Broad incumbents

• Aurobindo Pharma: One of India's largest vertically integrated pharmaceutical manufacturers with extensive API and finished dosage form portfolios. Overlaps with Skanttr's API offerings but at significantly greater scale and vertical integration.
• Piramal Pharma Solutions: Large Indian-headquartered CDMO offering integrated API and finished dosage form development and manufacturing globally. Operates at much larger scale but provides overlapping CDMO and API services to similar global customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/c/CMSSuperheroes
• LinkedInlinkedin.com/company/skanttr

Compliance16 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Skanttr